Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy

Acta Neurologica Scandinavica

Volumn 116, Issue 2, 2007, Pages 128-132

  Velioglu S K ^a   Gazioglu S ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Adverse effects; Antiepileptic drugs; EEG; Encephalopathy; Hypermmonemia; Non convulsive status epilepticus; Seizures; Valproic acid

Indexed keywords

AMMONIA; DIAZEPAM; LIVER ENZYME; MIDAZOLAM; PHENYTOIN; VALPROIC ACID;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CASE REPORT; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EEG ABNORMALITY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LOADING DRUG DOSE; MALE; MENTAL HEALTH; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; RECURRENT DISEASE; SEIZURE; SYNCOPE; TEMPORAL LOBE EPILEPSY; TREATMENT RESPONSE; VALPROATE INDUCED HYPERAMMONEMIC ENCEPHALOPATHY;

ADULT; AMMONIA; ANTICONVULSANTS; BRAIN; ELECTROENCEPHALOGRAPHY; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA; LIVER; MALE; MIDAZOLAM; PHENYTOIN; STATUS EPILEPTICUS; VALPROIC ACID;

EID: 34547416595     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00793.x     Document Type: Article

References (17)

1. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002 16 : 695 714.
2. Verrotti A, Trotta D, Morgese G, Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 2002 17 : 367 73.
3. Shahar E, Andraus J, Sagie-Lerman T, Savitzki D. Valproic acid therapy inducing absence status evolving into generalized seizures. Pediatr Neurol 2002 26 : 402 4.
4. Paul V. Inhibition of acute hyperammonemia-induced convulsions by systemically administered gamma aminobutyric acid in rats. Pharmacol Biochem Behav 2003 74 : 523 8.
5. Jayakumar AR, Sujatha R, Paul V. Effect of ammonia on motor function in adult rats. Brain Res Bull 1997 43 : 275 8.
6. Gaskins JD, Holt RJ, Postelnick M. Non-dosage-depended valproic acid-induced hyperammonemia and coma. Clin Pharm 1984 3 : 313 6.
7. Batshaw MI, Brusilow SW. Valproate-induced hyperammonemia. Ann Neurol 1982 11 : 319 21.
8. Zaret BS, Beckner RR, Marini AM, Wagle W, Passarelli C. Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction. Neurology 1982 32 : 205 8.
9. McCall M, Bourgeois JA. Valproic acid-induced hyperammonemia. J Clin Psychopharmacol 2004 24 : 521 6.
10. Vossler DG, Wilensky AJ, Cawthon DF et al. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy. Epilepsia 2002 43 : 154 9.
11. Brenner RP. Is it status? Epilepsia 2002 43 : 103 13.
12. Denays R, Kumba C, Lison D, De Bels D. First epileptic seizure induced by occupational nickel poisoning. Epilepsia 2005 46 : 961 2.
13. Cendes F, Andermann F, Carpenter S et al. Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor mediated excitotoxicity in humans. Ann Neurol 1995 37 : 123 6.
14. Reif A, Leonhard C, Möbner R, Lesch KP, Fallgatter AJ. Encephalopathy and myoclonus triggered by valproic acid. Prog Neuro-Psychopharm Biol Psych 2004 28 : 1061 3.
15. Zeiger MG. Deepening coma in an epileptic patient: the missing link to the urea cycle. Nephrol Dial Transplant 2002 17 : 1351 3.
16. Sackellares JC, Lee SI, Dreifuss FE. Stupor following administration of valproic acid to patients receiving other drugs. Epilepsia 1979 20 : 697 703.
17. Verroti A, Greco R, Morgese G et al. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res 1999 29 : 36 40.